Ionis Pharmaceuticals (IONS) PT Lowered to $90 at BofA Securities

July 9, 2026 11:54 AM

BofA Securities analyst Jason Gerberry lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $90.00 (from $111.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found